Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

NCT07183852 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT07183852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07183852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma
Lead sponsor
Vastra Gotaland Region
Phase
Phase 1
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
March 31, 2033
Enrollment
18 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cutaneous melanoma, metastatic uveal melanoma